Drugs Protein Production Small Molecule 
Drug Target Review
NOVEMBER 1, 2023
Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. 2013) 56, 2059-2073.
FDA Law Blog: Biosimilars
JULY 11, 2023
Koblitz — One of the most important questions FDA has to answer is whether a given product is appropriately characterized as a drug, biologic, device, food, cosmetic, or something entirely different. As we have explained before , that distinction is critical to assigning a particular product to the appropriate regulatory scheme.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dark Matter Blog
JULY 16, 2021
I wanted to use molecular biology to create drugs. Both companies were founded to explore new space for drug discovery related to RNA, representing the revolution in RNA-focused drug discovery that has happened in the past decade or so. My last stop at Arrakis Therapeutics is with a company targeting RNA with small molecules.
The Pharma Data
OCTOBER 14, 2020
is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates (designed to be eukaryotic ribosomal selective glycosides) that are formulated to treat rare and ultra-rare premature stop codon diseases. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA.
The Pharma Data
MARCH 23, 2022
Polymerase is a viral protein that directs how Ebola virus replicates its genome as it infects new hosts. Drugs that target polymerase could potentially treat Ebola virus infections and save lives. The researchers discovered that Ebola virus polymerase hijacks a cellular protein called GSPT1.
Codon
MARCH 20, 2023
Point-of-care peptide hormone production enabled by cell-free protein synthesis. Marine biofilm engineered to produce current in response to small molecules. Peroxisomal metabolic coupling improves fatty alcohol production from sole methanol in yeast. DeWinter MA. ACS Synthetic Biology. ACS Synthetic Biology.
Codon
MAY 30, 2023
Read Programming inactive RNA-binding small molecules into bioactive degraders. Read Maximizing protein production by keeping cells at optimal secretory stress levels using real-time control approaches. Read *MISATO - Machine learning dataset of protein-ligand complexes for structure-based drug discovery.
Expert insights. Personalized for you.
96 
Let's personalize your content